US Patent 11939389 BCMA chimeric antigen receptors and uses thereof
Patent 11939389 was granted and assigned to Novartis on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11939389 BCMA chimeric antigen receptors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
